Basics EyePoint Pharmaceuticals, Inc. Common Stock IPO Date: February 1, 2005 Sector: Healthcare Industry: Pharma Market Cap: $677.11M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.79% Avg Daily Range (30 D): $0.34 | 3.63% Avg Daily Range (90 D): $0.29 | 4.13% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): .6M Avg Daily Volume (90 D): .66M Trade Size Avg Trade Size (Sh.): 128 Avg Trade Size (Sh.) (30 D): 76 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 673 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $1.16M Avg Inst. Trade (90 D): $1.11M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.58M Avg Closing Trade (30 D): $1.04M Avg Closing Trade (90 D): $1.09M Avg Closing Volume: 126.64K     News Jul 16, 2025 @ 11:00 AM EyePoint Reports Inducement Grants Under NASDAQ Li... Source: Eyepoint Pharmaceuticals, Inc. May 16, 2025 @ 11:00 AM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Apr 30, 2025 @ 11:00 AM EyePoint to Report First Quarter 2025 Financial Re... Source: N/A Apr 16, 2025 @ 11:00 AM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Mar 27, 2025 @ 11:00 AM EyePoint to Present at 2025 RBC Capital Markets Op... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.42 $-.65 $-.65 Diluted EPS $-2.42 $-.65 $-.65 Revenue $ 56.04M $ 24.45M $ 11.59M Gross Profit $ $ $ Net Income / Loss $ -146.78M $ -45.2M $ -41.4M Operating Income / Loss $ -161.37M $ -48.84M $ -45.24M Cost of Revenue $ $ $ Net Cash Flow $ -185.86M $ -14.55M $ 19.87M PE Ratio     Splits Dec 09, 2020:   1:10 Jun 11, 2008:   1:4